Article
Evaluation of the possible association of PDCD-1 and LAG3 gene polymorphisms with hepatocellular carcinoma risk.
BMC medical genomics - 2 May 2023
Wei Jiankai, Liao Zhangxiu, Tao Ying, Liu Shuaiting
Abstract excerpt
PURPOSE: Programmed death-1 (PDCD-1) and lymphocyte activating 3 (LAG3), two important immunosuppressive molecules, play crucial roles in immune escape of tumor cells. This study evaluated the effects of PDCD-1 (rs10204525 and rs36084323), and LAG3 (rs870849 and rs1882545) gene polymorphisms on hepatocellular carcinoma (HCC) risk. METHODS: 341 patients with HCC and 350 cancer-free controls in the South Chinese...
Read the complete abstract on PubMed